We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Ultra-Fast Cameras Used To Visualize Molecular Activity

By LabMedica International staff writers
Posted on 23 Dec 2008
Print article
Scientists in Munich and Boston have been working with new three-dimensional (3D) imaging systems that use ultra-fast cameras to capture high resolution images of the molecular activity in laboratory mice engineered to develop lung cancer. With additional evaluation, the scientists reported the same approach could be used to study cancer in people.

The research was led by Dr. Vasilis Ntziachristos, director of the Institute for Biological and Medical Imaging at the Helmholtz Center (Munich, Germany), and Dr. Mark Niedre, assistant professor of electrical and computer engineering at Northeastern University (Boston, MA, USA). The technology involved required a sophisticated use of light. According to Dr. Niedre, they solved the problems associated with traditional infrared-imaging technology, resulting is a clearer image of molecular markers of inflammation and other lung disorders.

The inventory of genes and proteins associated with cancer and other diseases is growing rapidly: early in November 2008, for instance, scientists reported sequencing the whole genome of a cancer cell for the first time. Molecular imaging technology puts this data in context by allowing scientists to see biologic molecules in action inside diseased cells and tissues. Now, researchers have devised a molecular imaging technique that uses near-infrared light peer deeper into the body.

Fluorescent-protein tags can be generated to target nearly any biologic protein, be it an enzyme that helps cancer cells advance through surrounding tissue or a marker of arthritic inflammation. However, their use has been limited to shallow tissues in humans or to small animals. The markers are triggered by, and emit near-infrared or infrared light, which scatters in the tissue; the more tissue the light has to penetrate, the blurrier the images become. A new 3D near-infrared imaging system utilizes ultra-fast cameras to capture light that has not scattered. The technology been used to create clearer, higher-resolution images of the molecular workings of lung cancer in mice, and with further development, it might be used to study disease in thicker tissues and in humans.

This progress, according to the scientists, should quickly provide researchers with an inside look at how cancer metastasizes inside an animal. The scientists are now trying to determine the precise molecular mechanism that occurs as cancer spreads from one tumor site to another.

Related Links:
Helmholtz Center
Northeastern University

Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Community-Acquired Pneumonia Test
RIDA UNITY CAP Bac
New
Immunofluorescence Analyzer
MPQuanti

Print article

Channels

Clinical Chemistry

view channel
Image: The tiny clay-based materials can be customized for a range of medical applications (Photo courtesy of Angira Roy and Sam O’Keefe)

‘Brilliantly Luminous’ Nanoscale Chemical Tool to Improve Disease Detection

Thousands of commercially available glowing molecules known as fluorophores are commonly used in medical imaging, disease detection, biomarker tagging, and chemical analysis. They are also integral in... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Delivers Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Pathology

view channel
Image: The ready-to-use DUB enzyme assay kits accelerate routine DUB activity assays without compromising data quality (Photo courtesy of Adobe Stock)

Sensitive and Specific DUB Enzyme Assay Kits Require Minimal Setup Without Substrate Preparation

Ubiquitination and deubiquitination are two important physiological processes in the ubiquitin-proteasome system, responsible for protein degradation in cells. Deubiquitinating (DUB) enzymes contain around... Read more

Technology

view channel
Image: The HIV-1 self-testing chip will be capable of selectively detecting HIV in whole blood samples (Photo courtesy of Shutterstock)

Disposable Microchip Technology Could Selectively Detect HIV in Whole Blood Samples

As of the end of 2023, approximately 40 million people globally were living with HIV, and around 630,000 individuals died from AIDS-related illnesses that same year. Despite a substantial decline in deaths... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.